The reader of the prostate cancer literature is often stunned by the lack of evidence of efficacy of one form of treatment over that of others. Indeed, information suggests that "no treatment" may be an effective option. Analyzing the available literature that reports the results of treatment ...
Treatment options for localized prostate cancer It seems clear that thermal-based therapies of prostate cancer have the potential to completely eradicate the prostate gland. Technical modifications conti... MO Koch,TA Gardner - 《Current Treatment Options in Oncology》 被引量: 46发表: 2005年 Pharmaco...
Enucleative procedures. Enucleative procedures, such as holmium laser enucleation of the prostate (HoLEP), generally remove all the prostate tissue blocking urine flow and prevent regrowth of tissue. The removed tissue can be examined for prostate cancer and other conditions. These procedures are s...
Degarelix (Firmagon) is a LHRH antagonist used to treat advanced prostate cancer. It has been shown to decrease the progression of disease, but further trials are needed to look at long-term outcomes. It is fairly well tolerated with common side effects being local injection site problems and ...
For over 60 years the mainstay of treatment for patients who have advancing has been androgen deprivation therapy. Now there are new chemotherapeutic options, novel hormone manipulations, and other adjunctive therapies available. Based on a case presentation, the authors have attempted to outline for...
to symptoms like waking up at night to urinate. Having the urgent need to go. Or a weak stream. Left untreated, it can lead to more serious urinary, bladder and kidney problems. BPH may be a fact of life, but not one you need to live with. Start exploring your options here. Why ...
When testosterone levels rise during puberty, the prostate grows rapidly, doubling in size by age 20. Growth slows down for the next two decades and the prostate usually does not cause problems for many years. Less than 10% of 30-year-old men have an enlarged prostate. When a man reaches...
Las Vegas--Brachytherapy is a growing treatment choice for menwith low-risk prostate cancer, although it is still selected by less than22% of men with the disease, according to San Francisco researchers. Theuse of androgen ablation has also increased, the researchers found in ananalysis of ...
Stephenson: There are many treatment options for patients with prostate cancer. The most common treatment options involve either surgical removal of the prostate or radiation, which can be given through external beam radiation or through the implantation of radioactive seeds. These treatments, when ...
Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Despite introduction of various novel therapies, treatment options for metastatic castrate resistant prostate cancer (mCRPC) remain limited. This is a retr... N Mar,S Dwabe,MN ...